68.26 USD
↗ 1.28 (1.91%)AT CLOSE (11:59 AM EDT)
Xenon Pharmaceuticals Inc
XENENASDAQ • USD
69.22
↗ 0.96 (1.40%)
POST MARKET (AS OF 05:24 PM EDT)
Post Market
AS OF 05:24 PM EDT
69.22
↗ 0.96 (1.40%)
Market: CLOSED
Xenon Pharmaceuticals Inc (XENE) is currently trading at $68.20. XENE shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, XENE trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jul 17, 2026.
Open?$66.20
High?$69.58
Low?$66.18
Prev. Close?$66.98
Volume?1.3M
Avg. Volume?1.8M
VWAP?$68.61
Rel. Volume?0.76x
Bid / Ask
Bid?$59.47 × 100
Ask?$78.62 × 100
Spread?$19.15
Midpoint?$69.05
Valuation & Ratios
Market Cap?6.5B
Shares Out?96.7M
Float?68.7M
Float %?88.9%
P/E Ratio?N/A
P/B Ratio?4.84
EPS?-$3.96
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Employees
370
Market Cap
6.5B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-11-05
Address
200 - 3650 GILMORE WAY
BURNABY,
Phone: (604) 484-3300
BURNABY,
Phone: (604) 484-3300
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?36
Piotroski F-Score?0/9Weak
Altman Z-Score?77.88Safe
Confidence?49%Low
Short InterestElevated
Short % of Float?9.11%Elevated
Short Interest?6.3M
Days to Cover?3.0
Free Float68.7M
Avg Daily Volume2.1M
Settlement Date2026-06-30
Financial Health
Current Ratio?27.79Strong
Quick Ratio?27.79Strong
Cash Ratio?13.71Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.84FAIR▾
Peers100
S&P38
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-14.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-28.6%WEAK▾
S&P6
ROA?-27.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-307252000
Enterprise Value?$5.9B
Fundamentals ratios updated end of day